AirPods Pro 2 adds 'clinical grade' hearing aid feature

Scope of the New Feature & Device Support

  • Feature targets H2-chip devices; some expect it on AirPods 4, others note Apple only named AirPods Pro 2 in the FDA context, so broader support is unclear.
  • It’s being positioned as a regulated “medical device” use, with explicit mention of ongoing FDA and other-agency approvals.
  • Commenters expect AirPods Pro 2 to remain on sale for many years if they’re part of a medical device line.

How It Compares to Traditional Hearing Aids

  • Many report clinical hearing aids are very expensive (often thousands of dollars) and have poor music/Bluetooth quality versus AirPods/Bose/etc.
  • Lifespan estimates vary: some say ~3 years for “features like Bluetooth,” others indicate devices can last longer but become outdated.
  • Multiple people emphasize that proper hearing aids do complex, frequency-specific processing tailored to an audiogram; simply “turning up the volume” is not enough.
  • Experts in the thread say Apple’s solution is for mild–moderate loss and the “gap years” before full hearing aids, not a replacement for cochlear implants or serious loss.

AirPods Fit, Comfort & Daily Use

  • Strong divide on fit: some say AirPods Pro stay in through running; others say they constantly fall out regardless of stock tip size.
  • Many recommend third‑party tips (foam, wings, sleeves), custom molds, or hooks; foam tips improve isolation but degrade faster and can affect charging.
  • Wearing AirPods all day is considered difficult or uncomfortable by some, limiting their use as a full-time hearing aid.

Existing iOS Hearing Features & Apps

  • Several note that similar functionality already exists via:
    • iOS Headphone Accommodations + audiogram import.
    • Mimi hearing test app to generate an audiogram and sync it to Apple Health, then systemwide.
    • Conversation Boost on AirPods Pro for speech-in-noise enhancement.
  • Some report added processing modes can introduce latency and reduced quality compared to standard transparency.

Regulation, Market Impact & Cost Disruption

  • The new OTC hearing-aid category and deregulation are credited with enabling such products and lowering prices.
  • Hearing-aid industry is described as under-innovative, insular, and overpriced; Apple and others (e.g., Sony, Jabra, Sennheiser’s hearing-aid ties) are seen as potential disruptors.
  • Even with frequent AirPods replacement, some argue total cost can still undercut traditional aids.

Stigma, Accessibility & Social Dynamics

  • Multiple comments highlight stigma around visible hearing aids, especially for younger people; AirPods could normalize assistive hearing tech and serve as an “on-ramp.”
  • Others note a reverse issue: wearing AirPods can signal “I’m not listening,” which may be problematic in social or school settings.
  • Several users with borderline or situational hearing difficulty see this as a compelling middle ground vs. committing to multi‑thousand‑dollar aids.

Limitations, Safety, and Reliability Concerns

  • Some stress that hearing aids are medical devices with strict safety, robustness, and lifecycle requirements; concern exists about Apple potentially discontinuing support.
  • Others counter that workplaces should not rely solely on hearing for safety, but commenters with severe loss describe real risks if aids fail.
  • Battery life and wearing comfort are seen as key blockers to treating AirPods as full-time aids.

Other Observations & Open Questions

  • Questions remain about:
    • Whether the new mode is “clinical-grade” transparency or something more advanced.
    • All-day (12+ hour) battery options and support for features like CROS (single-sided deafness).
    • Android-compatible alternatives; the thread notes there are many new OTC options but does not converge on a specific best choice.
  • Some mention difficulty trying AirPods in-store; others suggest returns within 14 days or sanitized demo units in certain regions.